Tilray Medical, a division of Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY) and a leading global medical cannabis company, today announced the commercial launch of its first medical cannabis product in Panama, marking a significant milestone in the company’s ongoing global expansion and commitment to improving patient access to pharmaceutical-grade cannabinoid medicines worldwide.